Diamyd   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Stockholm Sweden (1994)

Organization Overview

First Clinical Trial
2004
NCT00456027
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Diamyd Inc | Diamyd Medical AB | Diamyd Therapeutics AB